| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Platin | CTRPv2 | pan-cancer | AAC | -0.0017 | 1 |
| mRNA | AZD8055 | GDSC1000 | pan-cancer | AAC | 0.0014 | 1 |
| mRNA | navitoclax:PLX-4032 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0015 | 1 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | 0.0012 | 1 |
| mRNA | BRD-K48334597 | CTRPv2 | pan-cancer | AAC | -0.0026 | 1 |
| mRNA | FSC231 | CTRPv2 | pan-cancer | AAC | 0.0026 | 1 |
| mRNA | MLN4924 | GDSC1000 | pan-cancer | AAC | -0.0013 | 1 |
| mRNA | Gefitinib | CTRPv2 | pan-cancer | AAC | 0.0012 | 1 |
| mRNA | BRD-K16130065 | CTRPv2 | pan-cancer | AAC | -0.0025 | 1 |
| mRNA | CIL41 | CTRPv2 | pan-cancer | AAC | 0.0017 | 1 |